According to sources, DCGI has convened a meeting in Delhi on August 10 to discuss matters related to the draft New Drugs, Medical Devices and Cosmetics Bill, 2023
Seek a separate 'Medical Devices Act' distinct from the drug regulations Bill
Abbott's diagnostic sales came in at $2.3 billion in the quarter, in line with analysts' average estimates.
Shares of J&J, which recently spun off its consumer health unit to focus on drugs and medical devices, rose about 2% in premarket trading
Medical devices of all four categories (A, B, C, and D) will be brought under the regulation by October 1 and as of now only two groups (A and B) are being regulated, Drugs Controller General of India (DCGI) Rajeev Singh Raghuvanshi said on Wednesday. Speaking to reporters on the sidelines of the 9th International Pharmaceutical Exhibition (iPHEX) being organised by the Pharmaceuticals Exports Promotion Council (Pharmexcil) here, Raghuvanshi said the regulations would ensure quality in the production of medical devices. "In the medical devices, we are categorising into four groups. Two groups (A and B) are already notified. C and D are left which will happen from October 1," he said. The Union Cabinet on April 26 approved the National Medical Devices Policy, 2023 to give a thrust to the sector with quality controls. The market size of the medical devices sector in India is estimated to be USD 11 billion (approximately Rs 90,000 crore) in 2020 and its share in the global medical devi
The pricing policy is a part of the National Medical Device Policy 2023 launched by the government to facilitate the growth of the sector while also ensuring accessibility and affordability
Applications have been invited for setting up more Jan Aushadhi Kendras as around 10,000 such centres are expected to be made functional by the year-end, a top official said on Friday. Ravi Dadhich, CEO of Pharmaceuticals and Medical Devices Bureau of India (PMBI) said, "10,000 Jan Aushadhi Kendras are expected to be functional across the country by the end of the year." He added that applications have been invited for the proposals to establish these centres. As on May 31, a total of 9,484 Jan Aushadhi Kendras are operational in the country. Dadhich made the comments in an interaction with media persons assembled at the central warehouse, Bilaspur, Gurugram. There are currently four warehouses in the country under Pradhan Mantri Bharatiya Jan Aushadhi Pariyojana (PMBJP), located at Gurugram (Haryana), Chennai, Guwahati and Surat, with the central warehouse at Gurugram being the largest. At present, PMBJP is providing 1,800 medicines, as well as 285 surgical devices at highly ...
Stalin's visit to Japan brings in investments worth Rs 1,300 crore
Omron will make devices including blood pressure monitors and will invest nearly 1.3 billion Indian rupees (about $15.7 million) to set up the plant, the sources said, declining to be identified ahead
The report by GlobalData, a leading data and analytics company, shows that the industry finds itself at a crucial juncture, balancing technological advancements with sustainable practices
The department of consumer affairs has mandated that pharmaceutical clearly display important information on their packaging so consumer can make informed decisions
Backed by growing healthcare needs and the government's commitment to facilitate growth, the Indian medical devices industry has the power to emerge as the global leader in manufacturing and innovation in the next 25 years, Union Health Minister Mansukh Mandaviya said on Tuesday. The medical devices sector is an essential and integral constituent of India's healthcare sector, he said during his interaction with representatives of Japanese medical devices companies in Tokyo. "The sector's contribution became even more prominent as India supported the domestic and global battle against COVID-19 pandemic through large scale production of medical devices and diagnostic kits," he said. Dr Mandaviya noted that the medical devices sector has the potential to grow from its current size of USD 11 billion to four times by 2030. He further stated that backed by growing health care needs and the government's commitment to facilitate growth, the Indian medical devices industry has the power to
Chief Minister Yogi Adityanath has reiterated his resolve to make the state a leading medical and pharmaceutical hub in the country
Medical devices maker Healthium Medtech on Monday said it has appointed Prashant Krishnan as global business head for advanced wound care and surgery portfolio. The appointment of Krishnan, who was earlier with Medtronic, comes at a time when the company is strengthening its portfolio in advanced surgery, wound care, orthopaedics and post-surgical care through organic and inorganic routes, Healthium Medtech said in a statement. Krishnan brings more than 27 years of experience and has led businesses across India, South Asia and the US in various leadership positions across surgery, cardiology and orthopaedics medical devices sector. He has also previously worked with companies like Johnson & Johnson and Godrej & Boyce. He holds a master's degree in Business Administration from Xavier Institute of Management and an alumni of The Wharton School, University of Pennsylvania, the company said.
This initiative has the potential to bring about significant positive changes in the healthcare sector of Uttar Pradesh and contribute to the overall growth of the region
Overall imports decline 8% in first nine months of FY23
The National Medical Devices Policy, 2023 will pave the way for India to become an 'end-to-end' healthcare resource centre not only for the country, but also for the global needs, industry bodies opined on Thursday. The government on Wednesday approved the new policy with an aim to promote domestic manufacturing and help the sunrise sector grow from the present USD 11 billion to USD 50 billion in the next five years and reduce import dependence. The policy focuses on six strategies to tap the potential of the sector with the 'implementation of action plan'. Ajay Singh, President of Assocham, said regulatory measures like single window for different types of licences, coherent pricing norms and infrastructure for manufacturing and technology advancement, are among the defining features of the new policy, as approved by the Union Cabinet. "While India has established itself as a 'pharmacy of the world', integrated healthcare would require equal emphasis on medical devices. "The new
Empowered group of secretaries, Aayog review some sectors to bring them to 'acceptable levels'
Group wants basic custom duty on import of medical devices increased to 10-15%
Union Minister for Science and Technology Jitendra Singh on Tuesday said India is among the top five countries in the world manufacturing life-saving high-risk medical devices but the cost of our devices is about one-third of those manufactured by the other four countries.Addressing the faculty and students after inaugurating the Combined Devices Block at Chitra Tribunal Institute of Medical Science and Technology here, Singh said, "technologies developed by the Institute like the artificial heart valve, hydrocephalus shunt, oxygenator and drug eluting Intra uterine device are being manufactured in three to four countries like USA, Japan, Brazil and China," said a press release by Ministry of Science & Technology.Singh said the world-class medical devices made indigenously are available to Indian patients at approximately one-fourth to the one-third price of their imported counterparts. He underlined that this reflects the Atmanirbhar vision of PM Modi to become self-reliant in .